Margarita GutiérrezGabriel A. VallejosCortes, MagdalenaMagdalenaCortesCarlos Bustos2025-04-152025-04-152019-01-2910.1111/cbdd.134562-s2.0-85060760001https://cris-uv-2.scimago.es/handle/123456789/2416WOS:000477026200016Abstract In recent years, the design, development, and evaluation of several inhibitors of the BACE1 enzyme, as part of Alzheimer's treatment, have gathered the scientific community's interest. Here, a linear regression model was built using binding free energy calculations through the Bennett acceptance ratio method for 20 known inhibitors of the BACE1 enzyme, with a Pearson coefficient of R = 0.88 and R 2 = 0.78. The validation of this model was verified employing eight additional random inhibitors, which also gave a linear correlation with R = 0.97 and R 2 = 0.93. Furthermore, this linear regression model was also used for proposing the structure of four potential BACE1 inhibitors, and the most active of them gave a theoretical K d = 10 nM. However, these molecules have not been synthesized yet. Our team used a total time of more than 800 ns for the Molecular Dynamics to carry out this study, and all the software used were freely available.enacceso restringidoBiochemistry And Molecular BiologyBiochemistryChemistry, MedicinalMolecular Medicinearticle